Tolerance of Infants Fed a Hydrolysate Formula
Public ClinicalTrials.gov record NCT03628183. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Tolerance of Infants Fed a Hydrolysate Formula Manufactured With a New Processing Method
Study identification
- NCT ID
- NCT03628183
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Abbott Nutrition
- Industry
- Enrollment
- 51 participants
Conditions and interventions
Conditions
Interventions
- Hydrolysate Infant Formula 1 Other
- Hydrolysate Infant Formula 2 Other
Other
Eligibility (public fields only)
- Age range
- Up to 14 Days
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 27, 2018
- Primary completion
- Nov 22, 2018
- Completion
- Nov 22, 2018
- Last update posted
- Dec 18, 2018
2018
United States locations
- U.S. sites
- 5
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Watching Over Mothers and Babies | Tucson | Arizona | 85712 | — |
| Springs Medical Research | Owensboro | Kentucky | 42303 | — |
| The Cleveland Pediatric Research Center, LLC | Cleveland | Ohio | 44130 | — |
| Institute of Clinical Research, LLC | Mentor | Ohio | 44060 | — |
| Midsouth Center for Clinical Research | Memphis | Tennessee | 38116 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03628183, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 18, 2018 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03628183 live on ClinicalTrials.gov.